{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T19:43:00Z","timestamp":1761939780505,"version":"build-2065373602"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/ndt\/gfl096","type":"journal-article","created":{"date-parts":[[2006,3,23]],"date-time":"2006-03-23T01:14:12Z","timestamp":1143076452000},"page":"1833-1837","source":"Crossref","is-referenced-by-count":4,"title":["Increased systolic blood pressure with rofecoxib in congenital furosemide-like salt loss"],"prefix":"10.1093","volume":"21","author":[{"given":"Martin","family":"K\u00f6mhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Nazarowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan C.","family":"Reinalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannsj\u00f6rg W.","family":"Seyberth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,3,22]]},"reference":[{"key":"key\n\t\t\t\t20171012212515_BIB1","doi-asserted-by":"crossref","unstructured":"Sowers JR, White WB, Pitt B et al. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med2005; 165: 161\u2013168","DOI":"10.1001\/archinte.165.2.161"},{"key":"key\n\t\t\t\t20171012212515_BIB2","doi-asserted-by":"crossref","unstructured":"Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med2004; 351: 1709\u20131711","DOI":"10.1056\/NEJMp048288"},{"key":"key\n\t\t\t\t20171012212515_BIB3","doi-asserted-by":"crossref","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med2005; 352: 1071\u20131080","DOI":"10.1056\/NEJMoa050405"},{"key":"key\n\t\t\t\t20171012212515_BIB4","doi-asserted-by":"crossref","unstructured":"Cullen L, Kelly L, Connor SO et al. Selective cyclooxygenase-2 inhibition by nimesulide in man. J Pharmacol Exp Ther1998; 287: 578\u2013582","DOI":"10.1016\/S0022-3565(24)37830-9"},{"key":"key\n\t\t\t\t20171012212515_BIB5","doi-asserted-by":"crossref","unstructured":"Catella-Lawson F, McAdam B, Morrison BW et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther1999; 289: 735\u2013741","DOI":"10.1016\/S0022-3565(24)38195-9"},{"key":"key\n\t\t\t\t20171012212515_BIB6","doi-asserted-by":"crossref","unstructured":"Eidelman RS, Hebert PR, Weisman SM et al. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med2003; 163: 2006\u20132010","DOI":"10.1001\/archinte.163.17.2006"},{"key":"key\n\t\t\t\t20171012212515_BIB7","doi-asserted-by":"crossref","unstructured":"Kramer BK, Kammerl MC, Komhoff M. Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications. Kidney Blood Press Res2004; 27: 43\u201362","DOI":"10.1159\/000075811"},{"key":"key\n\t\t\t\t20171012212515_BIB8","doi-asserted-by":"crossref","unstructured":"Brater DC, Harris C, Redfern JS et al. Renal effects of COX-2-selective inhibitors. Am J Nephrol2001; 21: 1\u201315","DOI":"10.1159\/000046212"},{"key":"key\n\t\t\t\t20171012212515_BIB9","doi-asserted-by":"crossref","unstructured":"Frishman WH. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. Am J Cardiol2002; 89: 18D\u201325D","DOI":"10.1016\/S0002-9149(02)02233-6"},{"key":"key\n\t\t\t\t20171012212515_BIB10","doi-asserted-by":"crossref","unstructured":"Reinalter SC, Jeck N, Peters M et al. Pharmacotyping of hypokalaemic salt-losing tubular disorders. Acta Physiol Scand2004; 181: 513\u2013521","DOI":"10.1111\/j.1365-201X.2004.01325.x"},{"key":"key\n\t\t\t\t20171012212515_BIB11","doi-asserted-by":"crossref","unstructured":"Jeck N, Schlingmann KP, Reinalter SC, Komhoff M, Peters M, Waldegger S and Seyberth HW. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol2005; 288: R782\u2013R795","DOI":"10.1152\/ajpregu.00600.2004"},{"key":"key\n\t\t\t\t20171012212515_BIB12","doi-asserted-by":"crossref","unstructured":"Komhoff M, Jeck ND, Seyberth HW et al. Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome. Kidney Int2000; 58: 2420\u20132424","DOI":"10.1046\/j.1523-1755.2000.00425.x"},{"key":"key\n\t\t\t\t20171012212515_BIB13","doi-asserted-by":"crossref","unstructured":"Komhoff M, Reinalter SC, Grone HJ et al. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatr Res2004; 55: 261\u2013266","DOI":"10.1203\/01.PDR.0000101747.09626.6B"},{"key":"key\n\t\t\t\t20171012212515_BIB14","doi-asserted-by":"crossref","unstructured":"Reinalter SC, Jeck N, Brochhausen C et al. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome\/antenatal Bartter syndrome. Kidney Int2002; 62: 253\u2013260","DOI":"10.1046\/j.1523-1755.2002.00435.x"},{"key":"key\n\t\t\t\t20171012212515_BIB15","doi-asserted-by":"crossref","unstructured":"de Man SA, Andre JL, Bachmann H et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens1991; 9: 109\u2013114","DOI":"10.1097\/00004872-199102000-00002"},{"key":"key\n\t\t\t\t20171012212515_BIB16","doi-asserted-by":"crossref","unstructured":"Soergel M, Kirschstein M, Busch C et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr1997; 130: 178\u2013184","DOI":"10.1016\/S0022-3476(97)70340-8"},{"key":"key\n\t\t\t\t20171012212515_BIB17","doi-asserted-by":"crossref","unstructured":"Leonhardt A, Busch C, Schweer H et al. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. Acta Paediatr1992; 81: 191\u2013196","DOI":"10.1111\/j.1651-2227.1992.tb12202.x"},{"key":"key\n\t\t\t\t20171012212515_BIB18","doi-asserted-by":"crossref","unstructured":"Murray R, Shipp E, FitzGerald GA. Prostaglandin endoperoxide\/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets. J Biol Chem1990; 265: 21\u2009670\u201321\u2009675","DOI":"10.1016\/S0021-9258(18)45792-4"},{"key":"key\n\t\t\t\t20171012212515_BIB19","doi-asserted-by":"crossref","unstructured":"Cheng Y, Austin SC, Rocca B et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science2002; 296: 539\u2013541","DOI":"10.1126\/science.1068711"},{"key":"key\n\t\t\t\t20171012212515_BIB20","doi-asserted-by":"crossref","unstructured":"Bartter FC, Pronove P, Gill JR,Jr. et al. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med1962; 33: 811\u2013828","DOI":"10.1016\/0002-9343(62)90214-0"},{"key":"key\n\t\t\t\t20171012212515_BIB21","doi-asserted-by":"crossref","unstructured":"Depre M, Ehrich E, Van Hecken A et al. Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans. Eur J Clin Pharmacol2000; 56: 167\u2013174","DOI":"10.1007\/s002280050736"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/7\/1833\/5156968\/gfl096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T03:27:10Z","timestamp":1736306830000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/7\/1833\/1821898\/Increased-systolic-blood-pressure-with-rofecoxib"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,22]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,3,22]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl096","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"type":"electronic","value":"1460-2385"},{"type":"print","value":"0931-0509"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,3,22]]}}}